KR101883825B1 - Manufacturing method of fermented cynanchum wilfordii and fermented cynanchum wilfordii manufactured by same method - Google Patents
Manufacturing method of fermented cynanchum wilfordii and fermented cynanchum wilfordii manufactured by same method Download PDFInfo
- Publication number
- KR101883825B1 KR101883825B1 KR1020160152706A KR20160152706A KR101883825B1 KR 101883825 B1 KR101883825 B1 KR 101883825B1 KR 1020160152706 A KR1020160152706 A KR 1020160152706A KR 20160152706 A KR20160152706 A KR 20160152706A KR 101883825 B1 KR101883825 B1 KR 101883825B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- extract
- present
- days
- bacillus subtilis
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 241000331432 Cynanchum wilfordii Species 0.000 title 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 33
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 21
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 19
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 13
- 206010061218 Inflammation Diseases 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 52
- 239000004480 active ingredient Substances 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 14
- 235000013376 functional food Nutrition 0.000 claims description 14
- 230000036541 health Effects 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 7
- 240000005384 Rhizopus oryzae Species 0.000 claims 2
- 235000013752 Rhizopus oryzae Nutrition 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 235000015278 beef Nutrition 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 238000011534 incubation Methods 0.000 description 21
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 18
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 10
- 230000002292 Radical scavenging effect Effects 0.000 description 9
- -1 fatty acid esters Chemical class 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 102000003390 tumor necrosis factor Human genes 0.000 description 8
- 241001474374 Blennius Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 102100040247 Tumor necrosis factor Human genes 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 210000002268 wool Anatomy 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000013527 bean curd Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DYQDHRLBSZIKEM-UHFFFAOYSA-N 1-[3-(2-acetyl-3,6-dihydroxyphenyl)-2,4-dihydroxyphenyl]ethanone Chemical compound CC(=O)C1=CC=C(O)C(C=2C(=C(O)C=CC=2O)C(C)=O)=C1O DYQDHRLBSZIKEM-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 240000009300 Apodytes dimidiata Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- PWXVHDBBWJSGOT-UHFFFAOYSA-N Cynandione A Natural products CC(=O)c1ccc(c(O)c1O)-c1c(O)ccc(C(C)=O)c1O PWXVHDBBWJSGOT-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000299452 Gouania lupuloides Species 0.000 description 1
- 235000000292 Gouania lupuloides Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
본 발명은 리조푸스 오리제 균주를 이용한 발효 백수오의 제조방법 및 상기 방법으로 제조된 발효 백수오에 관한 것이다. 리조푸스 오리제를 이용하여 본 발명의 방법으로 제조된 발효 백수오는 항산화 및 항염증 효능이 증진됨으로써, 항산화 및 항염증용 조성물로 유용하게 사용될 수 있다.The present invention relates to a method for producing fermented Bacillus subtilis using a Rythopus oryzae strain and a fermented Bacillus subtilis prepared by the method. Fermented white water produced by the method of the present invention using the Rissofus orientalis can be usefully used as a composition for antioxidant and anti-inflammation by enhancing the antioxidative and anti-inflammatory effects.
Description
본 발명은 발효 백수오의 제조방법 및 상기 방법으로 제조된 발효 백수오에 관한 것이다.The present invention relates to a process for producing fermented fermented milk and a fermented fermented milk produced by the process.
하수오는 중국이 원산지로 우리나라에 귀화한 덩굴성 다년생 초본이다. 우리나라 각지의 산야에 야생하고 내한성, 내충성, 내건성 등이 강해 전국에서 재배가 가능하다. 하수오는 적색과 백색 두 종류가 있는데 백하수오는 자양강장, 보혈, 익정(益精), 소종(消腫)의 효능이 있어, 병후쇠약, 빈혈, 조기백발, 신경쇠약, 만성풍비(慢性風痺) 등에 사용된다. 적하수오는 보간(補肝), 익신(益腎), 양혈(養血), 거풍(祛風), 영심안신(寧心安神), 익정(益精), 견골(堅骨), 화기혈(和氣血), 화허담(化虛痰), 오수발(烏鬚髮), 열안색(悅顔色), 장근골(長筋骨), 연년불로(延年不老)하는 효능이 있다. 대한약전외한약규격집에서는 적하수오를 하수오로, 백하수오를 백수오로 구분하여 규정하였다.Hassuo is a perennial herbaceous perennial native to China, native to China. It is possible to cultivate in the whole country because it is wild, cold tolerance, insecticide, and resistance to weather in the mountainside of each country. There are two kinds of red and white seaweeds. White seaweeds have the efficacy of nourishing tonic, blood, blood, echinacea, and leukemia, and are useful for the treatment of diseases such as debilitating anemia, anemia, early white hair, nervous breakdown, ). The enemy Suseo is a kind of aesthetics such as interpolation, exorcise, blood, breeze, 寧心安 神, 爱 精 精, 골 骨, It has an efficacy that it is a year-old unhealthy, and it has the efficacy that it is a year-round fire. In the Korean Pharmacopoeia, the standard of herbal medicines is defined by dividing the raw seaweed into seaweed and the white seaweed into white seaweed.
백수오는 박주가리과(Asclepiadaceae)에 속하며, 조롱, 새박풀, 해숭애, 새조롱, 곱뿌리 등의 다른 이름으로 불리기도 한다. 한방에서는 이들 초본 식물의 괴근(덩이뿌리)을 건조시킨 것을 나타낸다. 또한, 백수오의 덩이뿌리는 한방 소재로서 특히 백발을 검게 하는 효과가 있다. 건조되지 않은 백수오의 괴근은 장관 운동을 촉진하여 변비에 효과가 있다. Baeksoo is a member of the Asclepiadaceae family, and is sometimes referred to by other names such as mockery, dwarf, sunshine, new mockery, and root. In one room, the herbaceous plant root (root of root) was dried. In addition, the roots of white roots are one-component materials, and have an effect of darkening gray hair in particular. Unripe radish is effective in constipation by promoting intestinal motility.
백수오의 덩이뿌리는 치난콜(cynanchol), 시난디온 A(cynandione A), 강심 배당체, 아미노산 및 당 등의 활성 성분을 포함한다. 이중 시난디온 A는 IkB-α의 인산화 및 NF-κB가 핵내로 이동 하는 것을 억제함으로써 항염활성을 나타낸다. The roots of Bacillus subtilis include active ingredients such as cynanchol, cynandione A, cardiac glycosides, amino acids and sugars. Double synandione A exhibits anti-inflammatory activity by inhibiting the phosphorylation of IkB-a and the migration of NF-kB into the nucleus.
최근에는 백수오 또는 백수오의 덩이뿌리나 이들 추출 성분을 활용하여 의약품, 건강기능식품, 화장품 등의 소재로 활용하고자 하는 연구가 진행되고 있다. 예를 들어 백수오 추출물을 유효성분으로 함유하는 조성물의 혈관 질환 치료 용도가 대한민국 등록특허 제10-1041437호에 개시되어 있다. 또한, 백수오를 다른 생약 소재와 혼합한 복합 추출물의 탈모 방지 및 발모 촉진 용도나, 백수오 추출물의 수면장애 치료 용도 등이 보고되어 있다.In recent years, researches are being conducted to utilize the roots of papaya or papaya oyster roots or their extract components as materials for medicines, health functional foods, and cosmetics. For example, Korean Patent No. 10-1041437 discloses a composition for treating vascular disease in a composition containing an extract of Bacillus subtilis as an active ingredient. In addition, there has been reported a use of a combination extract of Bacillus subtilis mixed with other herbal materials for the prevention of hair loss and promotion of hair growth, and for the treatment of sleep disorders of Bacillus subtilis extract.
이에, 본 발명자들은 누룩균의 한 종인 리조푸스 오리제를 이용하여 제조한 발효 백수오가 항산화 및 항염증 효능이 있음을 확인함으로써, 본 발명을 완성하였다. Accordingly, the inventors of the present invention have completed the present invention by confirming that the fermented Bacillus anthracnose produced by using Rizufus orientalis, a kind of Bacillus subtilis, has an antioxidative and anti-inflammatory effect.
본 발명의 목적은, 리조푸스 오리제 균주를 이용하여 항산화 및 항염증 효능이 증진된 발효 백수오의 제조방법을 제공하는 것이다.It is an object of the present invention to provide a process for producing fermented Bacillus subtilis having an antioxidative and antiinflammatory activity enhanced by using a Rythopus oryzae strain.
본 발명의 다른 목적은, 상기 방법으로 제조된 발효 백수오를 제공하는 것이다.It is another object of the present invention to provide a fermented soybean curd prepared by the above method.
본 발명의 또 다른 목적은, 상기 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 화장료 조성물 또는 건강기능식품을 제공하는 것이다.It is still another object of the present invention to provide a cosmetic composition or a health functional food containing the fermented white ginseng extract or the extract thereof produced by the above method as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 리조푸스 오리제 균주를 접종하여 배양하는 것을 포함하는 항산화 및 항염증 효능이 증진된 발효 백수오의 제조방법을 제공한다.In order to achieve the above object, the present invention provides a method for producing fermented Bacillus subtilis having enhanced antioxidant and anti-inflammatory activity, comprising culturing the Bacillus subtilis strain inoculated with the Rispuss oryzae strain.
또한, 본 발명은 상기 방법으로 제조된 발효 백수오를 제공한다.In addition, the present invention provides a fermented soybean curd prepared by the above method.
또한, 본 발명은 상기 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항염증용 화장료 조성물을 제공한다.The present invention also provides an anti-inflammatory cosmetic composition containing fermented white ginseng or an extract thereof produced by the above method as an active ingredient.
또한, 본 발명은 상기 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항염증용 건강기능식품을 제공한다.In addition, the present invention provides an anti-inflammatory health functional food comprising fermented white ginseng or an extract thereof produced by the above method as an active ingredient.
또한, 본 발명은 상기 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항산화용 화장료 조성물을 제공한다.The present invention also provides an antioxidant cosmetic composition comprising fermented white ginseng or an extract thereof produced by the above method as an active ingredient.
아울러, 본 발명은 상기 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항산화용 건강기능식품을 제공한다.In addition, the present invention provides an antioxidant health functional food containing fermented white ginseng or its extract prepared by the above method as an active ingredient.
리조푸스 오리제를 이용하여 본 발명의 방법으로 제조된 발효 백수오는 항산화 및 항염증 효능이 증진됨으로써, 항산화 및 항염증용 조성물로 유용하게 사용될 수 있다.Fermented white water produced by the method of the present invention using the Rissofus orientalis can be usefully used as a composition for antioxidant and anti-inflammation by enhancing the antioxidative and anti-inflammatory effects.
도 1은 발효 백수오를 제조하는 방법을 나타낸 모식도이다.
도 2는 리조푸스 오리제를 이용하여 발효된 백수오를 촬영한 사진이다.
도 3은 발효 백수오 추출물의 세포 독성을 확인한 그래프이다. Y축은 대조군 대비 세포 생존율을 나타내며, X축은 처리한 발효 백수오 추출물(CW-RO)의 농도를 나타낸다.
도 4는 발효 백수오 추출물의 일산화질소 생성 억제 효과를 확인한 그래프이다. Y축은 아질산염 농도를 나타내며, X축은 처리한 발효 백수오 추출물(CW-RO)의 농도 및 LPS 처리 유무를 나타낸다.
도 5는 발효 백수오 추출물의 종양괴사인자(TNF-α) 발현 억제 효과를 확인한 그래프이다. Y축은 TNF-α의 농도를 나타내며, X축은 처리한 발효 백수오 추출물(CW-RO)의 농도 및 LPS 처리 유무를 나타낸다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic diagram showing a method for producing a fermented white bean.
Fig. 2 is a photograph of a white water fermented by using Rizoffus oryzae.
FIG. 3 is a graph showing cytotoxicity of the fermented Bacillus subtilis extract. FIG. The Y axis represents the cell survival rate as compared to the control group, and the X axis represents the concentration of the fermented white water extract (CW-RO) treated.
4 is a graph showing the inhibitory effect of nitrogen monoxide production on the fermented white water extract. The Y axis represents the nitrite concentration, and the X axis represents the concentration of the fermented white water extract (CW-RO) treated and the LPS treatment.
FIG. 5 is a graph showing the inhibitory effect on the tumor necrosis factor (TNF-α) expression of the fermented Bacillus subtilis extract. The Y-axis represents the concentration of TNF-α, and the X-axis represents the concentration of the fermented white water extract (CW-RO) and LPS treatment.
이하, 본 발명을 상세히 셜명한다.Hereinafter, the present invention will be described in detail.
본 발명은 리조푸스 오리제 균주를 접종하여 배양하는 것을 포함하는 항산화 및 항염증 효능이 증진된 발효 백수오의 제조방법을 제공한다.The present invention provides a method for producing fermented Bacillus subtilis with enhanced antioxidant and anti-inflammatory effects, which comprises culturing a Bacillus subtilis strain with inoculation.
상기 균주는 1×103 condia/㎖ 내지 1×109 condia/㎖, 구체적으로는 1×104 condia/㎖ 내지 1×108 condia/㎖, 더욱 구체적으로는 1×105 condia/㎖ 내지 1×107 condia/㎖의 농도로 접종될 수 있다. 본 발명의 일 실시예에서, 상기 균주는 1×106 condia/㎖의 농도로 접종될 수 있다. The strain may be used at a concentration of 1 x 10 3 condia / ml to 1 x 10 9 condia / ml, specifically 1 x 10 4 condia / ml to 1 x 10 8 condia / ml, more specifically 1 x 10 5 condia / 1 × 10 may be inoculated in a concentration of 7 condia / ㎖. In one embodiment of the invention, the strain may be inoculated at a concentration of 1x10 < 6 > condia / ml.
상기 배양은 20℃ 내지 40℃, 구체적으로는 25℃ 내지 35℃, 더욱 구체적으로는 28℃ 내지 32℃의 온도에서 수행될 수 있다. 본 발명의 일 실시예에서, 상기 배양 온도는 30℃일 수 있다. 배양 온도가 상기 범위를 벗어나면 리조푸스 오리제 균주의 활성이 저하되어 발효가 일어나지 않을 수 있다. 또한, 상기 배양 기간은 2일 내지 6일, 구체적으로는 3일 내지 5일일 수 있다. 본 발명의 일 실시예에서, 상기 배양 기간은 4일일 수 있다. 배양 기간이 너무 짧으면 발효가 충분히 일어나지 않으며, 배양 기간이 너무 길면 제조된 발효 백수오의 항산화능 및 항염증능이 오히려 저하될 수 있다.The cultivation may be carried out at a temperature of 20 ° C to 40 ° C, specifically, 25 ° C to 35 ° C, more specifically, 28 ° C to 32 ° C. In one embodiment of the invention, the incubation temperature may be 30 < 0 > C. If the incubation temperature is out of the above range, the activity of the Ricorpops oryzae strain is lowered and fermentation may not occur. The incubation period may be from 2 days to 6 days, more specifically from 3 days to 5 days. In one embodiment of the invention, the incubation period may be four days. If the incubation period is too short, the fermentation does not occur sufficiently. If the incubation period is too long, the antioxidant ability and antiinflammatory activity of the fermented white rot can be lowered.
본 발명의 구체적인 실시예에서, 본 발명자들은 리조푸스 오리제 균주를 이용하여 발효 백수오를 제조하였다.In a specific embodiment of the present invention, the present inventors have produced fermented Bacillus subtilis using a Rythopus oryzae strain.
또한, 본 발명은 본 발명의 방법으로 제조된 발효 백수오를 제공한다.In addition, the present invention provides a fermented soybean curd prepared by the method of the present invention.
상기 발효 백수오는 상술한 바와 같은 특징이 있다. 일례로, 본 발명의 제조방법은 백수오에 리조푸스 오리제 균주를 접종하여 배양할 수 있다. 상기 배양은 20℃ 내지 40℃, 구체적으로는 25℃ 내지 35℃, 더욱 구체적으로는 28℃ 내지 32℃의 온도에서 수행될 수 있다. 본 발명의 일 실시예에서, 상기 배양 온도는 30℃일 수 있다. 또한, 상기 배양 기간은 2일 내지 6일, 구체적으로는 3일 내지 5일일 수 있다. 본 발명의 일 실시예에서, 상기 배양 기간은 4일일 수 있다. The above fermented feed water has the above-described characteristics. For example, the production method of the present invention can be carried out by inoculating a strain of Bacillus subtilis oryzae. The cultivation may be carried out at a temperature of 20 ° C to 40 ° C, specifically, 25 ° C to 35 ° C, more specifically, 28 ° C to 32 ° C. In one embodiment of the invention, the incubation temperature may be 30 < 0 > C. The incubation period may be from 2 days to 6 days, more specifically from 3 days to 5 days. In one embodiment of the invention, the incubation period may be four days.
본 발명의 구체적인 실시예에서, 본 발명의 방법으로 제조된 발효 백수오는 항염증 성분인 시난디온 A의 함량뿐만 아니라, 라디칼 소거능도 증가하였다. 반면, 일산화질소 생성이나 종양괴사인자 발현은 억제시켰다(표 1 내지 2 및 도 3 내지 5 참조). In a specific embodiment of the present invention, the fermented white wool produced by the method of the present invention has an increased anti-inflammatory component, cinanideone content, as well as a radical scavenging ability. On the other hand, suppression of nitric oxide production or tumor necrosis factor expression was observed (see Tables 1 to 2 and 3 to 5).
또한, 본 발명은 본 발명의 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항염증용 화장료 조성물을 제공한다.The present invention also provides an anti-inflammatory cosmetic composition containing fermented white ginseng or an extract thereof produced by the method of the present invention as an active ingredient.
상기 발효 백수오는 상술한 바와 같은 특징이 있다. 일례로, 본 발명의 제조방법은 백수오에 리조푸스 오리제 균주를 접종하여 배양할 수 있다. 상기 배양은 20℃ 내지 40℃, 구체적으로는 25℃ 내지 35℃, 더욱 구체적으로는 28℃ 내지 32℃의 온도에서 수행될 수 있다. 본 발명의 일 실시예에서, 상기 배양 온도는 30℃일 수 있다. 또한, 상기 배양 기간은 2일 내지 6일, 구체적으로는 3일 내지 5일일 수 있다. 본 발명의 일 실시예에서, 상기 배양 기간은 4일일 수 있다. The above fermented feed water has the above-described characteristics. For example, the production method of the present invention can be carried out by inoculating a strain of Bacillus subtilis oryzae. The cultivation may be carried out at a temperature of 20 ° C to 40 ° C, specifically, 25 ° C to 35 ° C, more specifically, 28 ° C to 32 ° C. In one embodiment of the invention, the incubation temperature may be 30 < 0 > C. The incubation period may be from 2 days to 6 days, more specifically from 3 days to 5 days. In one embodiment of the invention, the incubation period may be four days.
본 발명의 제조방법에서 제조된 발효 백수오는 건조하여 추출하는 것을 더 포함할 수 있다. 상기 건조는 감압건조, 진공건조, 비등건조, 분무건조 또는 동결건조할 수 있다. 본 발명의 일 실시예에서, 상기 건조는 동결건조일 수 있다.The fermented white water produced by the production method of the present invention may further comprise drying and extracting. The drying may be reduced pressure drying, vacuum drying, boiling drying, spray drying or freeze drying. In one embodiment of the present invention, the drying may be freeze-drying.
상기 추출은 물, 알코올 또는 이들의 혼합물을 용매로 사용하여 추출할 수 있다. 상기 알코올은 구체적으로는 C1 내지 C4의 저급 알코올일 수 있으며, 더욱 구체적으로는 에탄올일 수 있다. 본 발명의 일 실시예에서, 상기 용매는 물일 수 있다. 이의 추출방법으로는 감압고온 추출, 열탕 추출, 여과법, 열수 추출, 침지 추출, 환류 추출, 냉침 추출, 증기 추출, 상온 추출 또는 초음파 추출 등 당 업계에 공지된 모든 통상적인 방법을 이용할 수 있다. 본 발명의 일 실시예에서, 추출방법은 열수 추출일 수 있다. The extraction can be carried out using water, alcohol or a mixture thereof as a solvent. The alcohol may specifically be a C 1 to C 4 lower alcohol, and more specifically may be ethanol. In one embodiment of the invention, the solvent may be water. As the extraction method, any conventional method known in the art can be used, such as extraction under reduced pressure, hot water extraction, filtration, hot water extraction, immersion extraction, reflux extraction, cold extraction, steam extraction, room temperature extraction or ultrasonic extraction. In one embodiment of the invention, the extraction method may be hot water extraction.
상기 추출은 10분 내지 4시간, 구체적으로는 30분 내지 3시간, 더욱 구체적으로는 50분 내지 2시간 동안 수행될 수 있다. 본 발명의 일 실시예에서, 상기 추출은 1시간 동안 수행될 수 있다. 아울러, 상기 추출 회수는 1회 내지 3회, 구체적으로는 1회 또는 2회 수행될 수 있다. 본 발명의 일 실시예에서, 상기 추출은 2회 수행될 수 있다.The extraction may be performed for 10 minutes to 4 hours, specifically 30 minutes to 3 hours, more specifically 50 minutes to 2 hours. In one embodiment of the invention, the extraction can be carried out for one hour. In addition, the number of times of extraction can be performed once to three times, specifically once or twice. In one embodiment of the present invention, the extraction may be performed twice.
본 발명의 구체적인 실시예에서, 본 발명의 방법으로 제조된 발효 백수오는 항염증 성분인 시난디온 A의 함량뿐만 아니라, 라디칼 소거능도 증가하였다. 반면, 일산화질소 생성이나 종양괴사인자 발현은 억제시켰다(표 1 내지 2 및 도 3 내지 5 참조). In a specific embodiment of the present invention, the fermented white wool produced by the method of the present invention has an increased anti-inflammatory component, cinanideone content, as well as a radical scavenging ability. On the other hand, suppression of nitric oxide production or tumor necrosis factor expression was observed (see Tables 1 to 2 and 3 to 5).
상기 화장료 조성물은 화장료 조성물 전체 중량에 대하여 본 발명의 발효 백수오 또는 이의 추출물을 0.1 내지 50중량%, 구체적으로는 1 내지 10 중량%의 양으로 첨가할 수 있다. 그러나 상기 비율은 화장품의 형태나, 구체적인 적용 부위 및 적용 용량에 따라 달라질 수 있다.The cosmetic composition may be added in an amount of 0.1 to 50% by weight, specifically 1 to 10% by weight, based on the total weight of the cosmetic composition. However, the above ratio may vary depending on the form of the cosmetic product, the specific application site and the application capacity.
본 발명의 화장료 조성물은 상기 발효 백수오 및 이의 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들이 포함되며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The cosmetic composition of the present invention includes components commonly used in cosmetic compositions in addition to the above-mentioned fermented white ginseng extract and its extracts, and includes conventional additives such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, .
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 페이스트, 크림, 젤, 파우더, 스프레이, 용액, 유탁액, 현탁액(무수 및 수계), 계면활성제-함유 클렌징, 무수 생성물(오일 및 글리콜계), 마스크, 팩, 분말, 로션, 비누, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 등으로 제형화될 수 있다. 구체적으로, 유연 화장수(스킨), 영양 화장수(밀크로션), 영양 크림, 맛사지 크림, 에센스, 아이크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared in any formulations conventionally produced in the art, and can be prepared, for example, in the form of paste, cream, gel, powder, spray, solution, emulsion, suspension (anhydrous and aqueous) - containing cleansing, anhydrous products (oil and glycol), masks, packs, powders, lotions, soaps, oils, powder foundations, emulsion foundations, wax foundations and the like. Specifically, it can be manufactured in the form of a flexible lotion (skin), a nutritional lotion (milk lotion), a nutritional cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray or a powder.
본 발명의 제형이 페이스트, 크림 또는 젤인 경우에는, 담체 성분으로 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, a cream or a gel, an animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, Can be used.
본 발명의 제형이 파우더 또는 스프레이인 경우에는, 담체 성분으로 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는, 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, a chlorofluorohydrocarbon , Propane / butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는, 담체 성분으로 용매, 용해화제 또는 유탁화제가 이용될 수 있다. 이의 예로는, 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent may be used as a carrier component. Examples thereof include fatty acid esters of water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는, 담체 성분으로 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라가칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Crystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, and the like can be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters.
또한, 본 발명은 본 발명의 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항염증용 건강기능식품을 제공한다.The present invention also provides an anti-inflammatory health functional food comprising fermented white ginseng or an extract thereof produced by the method of the present invention as an active ingredient.
상기 발효 백수오는 상술한 바와 같은 특징이 있다. 일례로, 본 발명의 제조방법은 백수오에 리조푸스 오리제 균주를 접종하여 배양할 수 있다. 상기 배양은 20℃ 내지 40℃, 구체적으로는 25℃ 내지 35℃, 더욱 구체적으로는 28℃ 내지 32℃의 온도에서 수행될 수 있다. 본 발명의 일 실시예에서, 상기 배양 온도는 30℃일 수 있다. 또한, 상기 배양 기간은 2일 내지 6일, 구체적으로는 3일 내지 5일일 수 있다. 본 발명의 일 실시예에서, 상기 배양 기간은 4일일 수 있다. The above fermented feed water has the above-described characteristics. For example, the production method of the present invention can be carried out by inoculating a strain of Bacillus subtilis oryzae. The cultivation may be carried out at a temperature of 20 ° C to 40 ° C, specifically, 25 ° C to 35 ° C, more specifically, 28 ° C to 32 ° C. In one embodiment of the invention, the incubation temperature may be 30 < 0 > C. The incubation period may be from 2 days to 6 days, more specifically from 3 days to 5 days. In one embodiment of the invention, the incubation period may be four days.
상기 추출물은 상술한 바와 같은 특징이 있다.The extract has the above-described characteristics.
본 발명의 구체적인 실시예에서, 본 발명의 방법으로 제조된 발효 백수오는 항염증 성분인 시난디온 A의 함량뿐만 아니라, 라디칼 소거능도 증가하였다. 반면, 일산화질소 생성이나 종양괴사인자 발현은 억제시켰다(표 1 내지 2 및 도 3 내지 5 참조). In a specific embodiment of the present invention, the fermented white wool produced by the method of the present invention has an increased anti-inflammatory component, cinanideone content, as well as a radical scavenging ability. On the other hand, suppression of nitric oxide production or tumor necrosis factor expression was observed (see Tables 1 to 2 and 3 to 5).
상기 건강기능식품에 첨가되는 유효성분인 발효 백수오 또는 이의 추출물의 함량은 목적에 따라 결정될 수 있다. 일반적으로, 전체 건강기능식품 중량의 0.01 내지 90 중량부일 수 있다.The content of the fermented Bacillus anthracis extract or its extract, which is an active ingredient added to the health functional food, can be determined depending on the purpose. Generally, it may be 0.01 to 90 parts by weight of the total weight of the health functional food.
또한, 상기 건강기능식품의 형태 및 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 건강기능식품의 형태는 정제, 캅셀, 분말, 과립, 액상 또는 환 등일 수 있다. There is no particular limitation on the form and kind of the health functional food. The form of the health functional food to which the substance can be added may be a tablet, a capsule, a powder, a granule, a liquid or a ring.
본 발명의 건강기능식품은 통상의 건강기능식품과 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등과 같은 당알코올을 포함할 수 있다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린 또는 아스파르탐과 같은 합성 감미제 등이 사용될 수 있다.The health functional food of the present invention may contain various flavoring agents or natural carbohydrates as an additional ingredient such as a normal health functional food. Such natural carbohydrates may include sugar alcohols such as monosaccharides such as glucose and fructose, polysaccharides such as disaccharides such as maltose and sucrose, dextrin, cyclodextrins, xylitol, sorbitol, erythritol and the like . As the sweetening agent, natural sweetening agents such as tau Martin and stevia extract, synthetic sweetening agents such as saccharine or aspartame, and the like may be used.
상기 외에 본 발명의 건강기능식품은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린 또는 알코올 등을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용될 수 있다. 이러한 첨가제의 비율은 본 발명의 조성물 100 중량부당 0.01~0.1 중량부의 범위에서 선택될 수 있다.In addition to the above, the health functional food of the present invention may contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and its salts, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, Alcohol, and the like. These components may be used independently or in combination. The proportion of such additives may be selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.
또한, 본 발명은 본 발명의 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항산화용 화장료 조성물을 제공한다.The present invention also provides an antioxidative cosmetic composition comprising fermented white ginseng or an extract thereof produced by the method of the present invention as an active ingredient.
상기 발효 백수오는 상술한 바와 같은 특징이 있다. 일례로, 본 발명의 제조방법은 백수오에 리조푸스 오리제 균주를 접종하여 배양할 수 있다. 상기 배양은 20℃ 내지 40℃, 구체적으로는 25℃ 내지 35℃, 더욱 구체적으로는 28℃ 내지 32℃의 온도에서 수행될 수 있다. 본 발명의 일 실시예에서, 상기 배양 온도는 30℃일 수 있다. 또한, 상기 배양 기간은 2일 내지 6일, 구체적으로는 3일 내지 5일일 수 있다. 본 발명의 일 실시예에서, 상기 배양 기간은 4일일 수 있다. The above fermented feed water has the above-described characteristics. For example, the production method of the present invention can be carried out by inoculating a strain of Bacillus subtilis oryzae. The cultivation may be carried out at a temperature of 20 ° C to 40 ° C, specifically, 25 ° C to 35 ° C, more specifically, 28 ° C to 32 ° C. In one embodiment of the invention, the incubation temperature may be 30 < 0 > C. The incubation period may be from 2 days to 6 days, more specifically from 3 days to 5 days. In one embodiment of the invention, the incubation period may be four days.
상기 추출물은 상술한 바와 같은 특징이 있다.The extract has the above-described characteristics.
본 발명의 구체적인 실시예에서, 본 발명의 방법으로 제조된 발효 백수오는 항염증 성분인 시난디온 A의 함량뿐만 아니라, 라디칼 소거능도 증가하였다. 반면, 일산화질소 생성이나 종양괴사인자 발현은 억제시켰다(표 1 내지 2 및 도 3 내지 5 참조). In a specific embodiment of the present invention, the fermented white wool produced by the method of the present invention has an increased anti-inflammatory component, cinanideone content, as well as a radical scavenging ability. On the other hand, suppression of nitric oxide production or tumor necrosis factor expression was observed (see Tables 1 to 2 and 3 to 5).
또한, 본 발명은 본 발명의 방법으로 제조된 발효 백수오 또는 이의 추출물을 유효성분으로 함유하는 항산화용 건강기능식품을 제공한다.The present invention also provides an antioxidant health functional food containing fermented white ginseng or an extract thereof produced by the method of the present invention as an active ingredient.
상기 발효 백수오는 상술한 바와 같은 특징이 있다. 일례로, 본 발명의 제조방법은 백수오에 리조푸스 오리제 균주를 접종하여 배양할 수 있다. 상기 배양은 20℃ 내지 40℃, 구체적으로는 25℃ 내지 35℃, 더욱 구체적으로는 28℃ 내지 32℃의 온도에서 수행될 수 있다. 본 발명의 일 실시예에서, 상기 배양 온도는 30℃일 수 있다. 또한, 상기 배양 기간은 2일 내지 6일, 구체적으로는 3일 내지 5일일 수 있다. 본 발명의 일 실시예에서, 상기 배양 기간은 4일일 수 있다. The above fermented feed water has the above-described characteristics. For example, the production method of the present invention can be carried out by inoculating a strain of Bacillus subtilis oryzae. The cultivation may be carried out at a temperature of 20 ° C to 40 ° C, specifically, 25 ° C to 35 ° C, more specifically, 28 ° C to 32 ° C. In one embodiment of the invention, the incubation temperature may be 30 < 0 > C. The incubation period may be from 2 days to 6 days, more specifically from 3 days to 5 days. In one embodiment of the invention, the incubation period may be four days.
상기 추출물은 상술한 바와 같은 특징이 있다.The extract has the above-described characteristics.
본 발명의 구체적인 실시예에서, 본 발명의 방법으로 제조된 발효 백수오는 항염증 성분인 시난디온 A의 함량뿐만 아니라, 라디칼 소거능도 증가하였다. 반면, 일산화질소 생성이나 종양괴사인자 발현은 억제시켰다(표 1 내지 2 및 도 3 내지 5 참조). In a specific embodiment of the present invention, the fermented white wool produced by the method of the present invention has an increased anti-inflammatory component, cinanideone content, as well as a radical scavenging ability. On the other hand, suppression of nitric oxide production or tumor necrosis factor expression was observed (see Tables 1 to 2 and 3 to 5).
이하, 본 발명을 하기 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by the following examples.
단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 이들에 의하여 한정되는 것은 아니다.However, the following examples are illustrative of the present invention, and the contents of the present invention are not limited thereto.
리조푸스Risofus 오리제Orissa 균주를 이용한 발효 Fermentation using strain 백수오의White 제조 Produce
3년근 백수오(영주, 한국)를 멸균하고, 여기에 1×106 condia/㎖의 농도로 리조푸스 오리제(Rhizopus oryzae, RO)(국립농업과학원, 한국) 균주를 접종하였다. 이를 30℃에서 4일 동안 배양하여 발효 백수오를 제조하였다(도 1 및 도 2). 이때, 대조군으로서 균주를 접종하지 않은 발효 백수오를 제조하였다.3-year-old white water five (Prince, Korea) and a sterile, 1 × 10 6 condia / ㎖ concentration in the separation tank crispus duck (Rhizopus of here oryzae , RO) (National Academy of Agricultural Science, Korea). This was cultivated at 30 DEG C for 4 days to prepare fermented white pears (FIGS. 1 and 2). At this time, fermented Bacillus subtilis not inoculated with the strain was prepared as a control.
발효 Fermentation 백수오Baewooo Oh 추출물의 제조 Preparation of extract
발효 백수오 및 대조군인 백수오의 열수 추출물을 다음과 같은 방법으로 제조하였다.The hot water extract of fermented Bacillus subtilis and control Bacillus subtilis was prepared by the following method.
구체적으로, 발효 백수오 및 대조군 백수오의 열수 추출물을 제조하기 위해 상기 <실시예 1>에서 제조된 발효 백수오를 건조시키고, 5 g의 건조된 발효 백수오에, 100 ㎖의 끓인 증류수를 첨가하였다. 이를 50/60 HZ, 700W의 전압조건으로 초음파균질기(Power Sonic 420, Hwashin Co., 한국)를 이용해 1시간씩 2회 추출한 후, 와트만 No.2 여과지를 이용해 추출물을 여과시켰다. 회전진공농축기(BUCHI, USA)로 50℃ 이하에서 여과액을 감압 농축한 후, 이를 동결건조시켜 파우더로 제조하여 시료로 준비하였다.Specifically, to prepare a hot-water extract of fermented Bacillus subtilis and control Bacillus subtilis, the fermented white water produced in the above <Example 1> was dried, and 100 g of boiled distilled water was added to 5 g of dried fermented bacilli . The extract was extracted twice using an ultrasonic homogenizer (Power Sonic 420, Hwashin Co., Korea) for 1 hour at a voltage of 50/60 Hz and 700W, and the extract was filtered using Watman No.2 filter paper. The filtrate was concentrated under reduced pressure at a temperature of 50 ° C or below by using a rotary vacuum concentrator (BUCHI, USA), and then freeze-dried to prepare a powder.
발효 Fermentation 백수오Baewooo Oh 추출물의 독성 확인 Toxicity of extracts
발효 백수오 추출물에 의한 세포 독성을 MTT 방법으로 확인하였다. The cytotoxicity of fermented Bacillus subtilis extract was confirmed by MTT method.
구체적으로, RAW 264.7 세포를 96 웰 플레이트에 웰 당 5×103 cells/㎖ 농도로 접종하고 하루 동안 배양한 후, <실시예 2>에서 제조된 50 uM, 100 uM, 200 uM 또는 400 uM 농도의 발효 백수오 추출물을 세포에 첨가하였다. 이를 3일 동안 37℃, 5% C02 항온기에서 배양하고 통상적인 MTT 방법에 따라 세포독성을 확인하였다. Specifically, RAW 264.7 cells were inoculated in a 96-well plate at a concentration of 5 × 10 3 cells / ml per well and cultured for one day. Then, the cells were cultured in the same manner as in Example 2 except that 50 μM, 100 μM, 200 μM or 400 μM Were added to the cells. It was cultured in a 5% CO 2 incubator at 37 ° C for 3 days, and cytotoxicity was confirmed by the conventional MTT method.
그 결과, 400 ㎍/㎖ 농도의 발효 백수오 추출물에 의해서도 세포독성이 나타나지 않았다(도 3).As a result, no cytotoxicity was observed by the fermented white water extract of 400 / / ml concentration (FIG. 3).
<< 실험예Experimental Example 1> 발효 1> Fermentation 백수오의White 유효성분 분석 Active ingredient analysis
<실시예 2>에서 제조된 발효 백수오 추출물의 유효성분은 UPLC(Ultra Pressure Liquid Chromatography)를 이용하여 분석하였다.The active ingredients of the fermented white water extract prepared in Example 2 were analyzed by UPLC (Ultra Pressure Liquid Chromatography).
구체적으로, 컬럼으로는 ACQUITY UPLC BEH C18(1.7 ㎛, 2.1×50 ㎜)을 사용하였고, 이동상으로 용매A(0.2%의 아세트산을 함유한 물)와 용매B(100% 아세토니트릴)를 0.5 ㎖/min의 유속으로 기울기 용리하였다. 또한, PDA(Waters, Aquity UPLC) 검출기를 사용하여 250 nm 파장에서 시난디온 A의 함량을 측정하였다. 실험은 세번 반복한 값의 평균±표준편차(mean±SD)로 나타내었다.Specifically, ACQUITY UPLC BEH C18 (1.7 탆, 2.1 횞 50 ㎜) was used as the column, and solvent A (water containing 0.2% acetic acid) and solvent B (100% acetonitrile) min. < / RTI > The content of cinanideone A was measured at a wavelength of 250 nm using a PDA (Waters, Aquity UPLC) detector. The experiment was expressed as the mean ± standard deviation (mean ± SD) of the values repeated three times.
그 결과, 표 1에 나타낸 바와 같이, 백수오 100 g당 시난디온 A 함량이 대조군인 백수오의 추출물은 37.85±0.023 mg이었으나, 발효 백수오의 추출물은 100.77±0.164 mg으로 약 3배 이상 증가하였다(표 1). As a result, as shown in Table 1, the extract of Bacillus subtilis, which is a control group, was 37.85 ± 0.023 mg per 100 g of Bacillus subtilis, but the extract of Bacillus subtilis was 100.77 ± 0.164 mg more than three times (Table 1).
<< 실험예Experimental Example 2> 발효 2> Fermentation 백수오의White 항산화 효능 확인 Check antioxidant efficacy
<실시예 2>에서 제조된 발효 백수오 추출물의 항산화 효능은 DPPH 라디칼 소거능을 분석하여 확인하였다.The antioxidant activity of the fermented white water extract prepared in Example 2 was confirmed by analyzing DPPH radical scavenging ability.
구체적으로, 먼저 DPPH(Sigma) 용액에 80% 에탄올을 혼합하여 100 μM 농도의 라디칼 용액을 제조하였다. 제조된 라디칼 용액과 <실시예 2>에서 제조된 추출물 각각을 혼합하여 차광조건에서 30분 동안 방치하였다. 이후, 517 nm 파장에서 분광광도계로 상기 혼합물의 흡광도를 측정하여, 라디칼 소거능을 계산하였다. 양성대조군으로 대표적인 항산화 물질인 아스코르브산을 사용하였다. 실험은 세번 반복한 값의 평균±표준편차(mean±SD)로 나타내었다.Specifically, 80% ethanol was mixed with DPPH (Sigma) solution to prepare a radical solution having a concentration of 100 μM. The prepared radical solution and each of the extracts prepared in Example 2 were mixed and allowed to stand under light-shielding conditions for 30 minutes. Then, the absorbance of the mixture was measured by a spectrophotometer at a wavelength of 517 nm, and a radical scavenging ability was calculated. As a positive control, ascorbic acid, a typical antioxidant, was used. The experiment was expressed as the mean ± standard deviation (mean ± SD) of the values repeated three times.
그 결과, 표 2에 나타낸 바와 같이, 발효 백수오 추출물(CW/RO)의 라디칼 소거능이 26.30±1.894%로 대조군인 백수오(CW) 추출물보다 약 2배 이상 증가하였다(표 2). As a result, as shown in Table 2, the radical scavenging ability of the fermented white water extract (CW / RO) was 26.30 ± 1.894%, which was about twice that of the control CW extract (Table 2).
<< 실험예Experimental Example 3> 발효 3> Fermentation 백수오의White 항염증 효능 확인 Confirming anti-inflammatory efficacy
<3-1> 일산화질소 생성 억제 효과 확인≪ 3-1 > Confirmation of Nitric Oxide Production Inhibitory Effect
<실시예 2>에서 제조된 발효 백수오 추출물의 일산화질소 생성 억제 여부를 다음과 같은 방법으로 분석하였다.The inhibition of nitrogen monoxide production of the fermented white water extract prepared in Example 2 was analyzed by the following method.
구체적으로, RAW 264.7 세포를 96 웰 플레이트에 웰 당 2 ×104 cells/㎖의 농도로 접종하고 하루 동안 배양한 후, <실시예 2>에서 제조된 50 uM, 100 uM, 200 uM 또는 400 uM 농도의 발효 백수오 추출물을 세포에 첨가하였다. 이를 2시간 동안 배양하고, 1 ㎍/㎖ 농도의 LPS를 처리하여 18시간 동안 더 배양하였다. 배양 후, 배양액을 그리스(Griess) 시약(Promega)과 1:1의 비율로 혼합하여 상온에서 차광 조건하에 10분 동안 반응시켰다. 이후, 540 nm 파장에서 분광광도계로 상기 혼합물의 흡광도를 측정하였다. Specifically, RAW 264.7 cells were inoculated to a 96-well plate at a concentration of 2 × 10 4 cells / ml per well and cultured for one day. Then, 50 μM, 100 μM, 200 μM or 400 μM Concentration of fermented Bacillus subtilis extract was added to the cells. This was incubated for 2 hours, and further treated with 1 μg / ml of LPS and incubated for 18 hours. After the culture, the culture solution was mixed with Griess reagent (Promega) at a ratio of 1: 1 and reacted for 10 minutes at room temperature under light shielding conditions. The absorbance of the mixture was then measured with a spectrophotometer at a wavelength of 540 nm.
그 결과, 발효 백수오 추출물이 농도 의존적으로 일산화질소의 생성을 억제하였다(도 4).As a result, the fermented Bacillus subtilis extract inhibited the production of nitrogen monoxide in a concentration-dependent manner (Fig. 4).
<3-2> 종양괴사인자 발현 억제 효과 확인≪ 3-2 > Confirmation of tumor necrosis factor expression inhibitory effect
<실시예 2>에서 제조된 발효 백수오 추출물의 종양괴사인자 발현 억제 효과를 다음과 같은 방법으로 분석하였다.The inhibitory effect of the fermented white water extract prepared in Example 2 on tumor necrosis factor expression was analyzed by the following method.
구체적으로, RAW 264.7 세포를 96 웰 플레이트에 웰 당 2 ×104 cells/㎖의 농도로 접종하고 하루 동안 배양한 후, <실시예 2>에서 제조된 50 uM, 100 uM, 200 uM 또는 400 uM 농도의 발효 백수오 추출물을 세포에 첨가하였다. 이를 2시간 동안 배양하고, 1 ㎍/㎖ 농도의 LPS를 처리하여 24시간 동안 더 배양하였다. TNF-α 농도는 TNF alpha mouse ELISA kit(Abcam)를 사용하여 제조사의 방법에 따라 측정하였다.Specifically, RAW 264.7 cells were inoculated to a 96-well plate at a concentration of 2 × 10 4 cells / ml per well and cultured for one day. Then, 50 μM, 100 μM, 200 μM or 400 μM Concentration of fermented Bacillus subtilis extract was added to the cells. The cells were cultured for 2 hours, further treated with 1 μg / ml of LPS and cultured for 24 hours. TNF-α levels were measured by the manufacturer's method using a TNF alpha mouse ELISA kit (Abcam).
그 결과, 발효 백수오 추출물이 통계적으로 유의미하게(*p<0.05, **p<0.01) 농도 의존적으로 TNF-α의 발현을 억제하였다(도 5).As a result, the expression of TNF-α was inhibited in a concentration-dependent manner (FIG. 5) in a statistically significant manner ( * p <0.05, ** p <0.01).
Claims (11)
A method for producing fermented Bacillus subtilis having enhanced antioxidant and anti-inflammatory activity, comprising a fermentation step in which a strain of Rhizopus oryzae is inoculated and cultured.
The method according to claim 1, wherein the strain is inoculated at a concentration of 1 × 10 3 condia / ml to 1 × 10 9 condia / ml.
The method according to claim 1, wherein the cultivation is carried out at a temperature of 20 ° C to 40 ° C.
The method according to claim 1, wherein the cultivation is performed for 2 days to 6 days.
A fermented beef cattle produced by the method of claim 1.
상기 발효 단계에 의해서 제조된 발효 백수오를 열수로 추출하는 추출 단계를 포함하는, 발효 백수오 추출물의 제조방법.
A fermentation step in which a strain of Rhizopus oryzae is inoculated and cultured; And
And an extraction step of extracting the fermented white water produced by the fermentation step with hot water.
An anti-inflammatory cosmetic composition comprising the fermented white ginseng or the extract of claim 5 as an active ingredient.
The cosmetic composition for anti-inflammation according to claim 7, wherein the extract is extracted using water, a C 1 to C 4 lower alcohol or a mixture thereof as a solvent.
An anti-inflammatory health functional food comprising the fermented white ginseng or the extract of claim 5 as an active ingredient.
An antioxidative cosmetic composition comprising the fermented white ginseng or the extract of claim 5 as an active ingredient.
An antioxidant health food containing the fermented white ginseng or the extract of claim 5 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160152706A KR101883825B1 (en) | 2016-11-16 | 2016-11-16 | Manufacturing method of fermented cynanchum wilfordii and fermented cynanchum wilfordii manufactured by same method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160152706A KR101883825B1 (en) | 2016-11-16 | 2016-11-16 | Manufacturing method of fermented cynanchum wilfordii and fermented cynanchum wilfordii manufactured by same method |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180055962A KR20180055962A (en) | 2018-05-28 |
KR101883825B1 true KR101883825B1 (en) | 2018-08-02 |
Family
ID=62451572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160152706A KR101883825B1 (en) | 2016-11-16 | 2016-11-16 | Manufacturing method of fermented cynanchum wilfordii and fermented cynanchum wilfordii manufactured by same method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101883825B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100616914B1 (en) * | 2004-10-26 | 2006-08-31 | 주식회사 국순당 | Composition for treating or preventing gastritis and peptic ulcer comprising Rhizopus sp. |
KR20140052576A (en) * | 2012-10-25 | 2014-05-07 | 코웨이 주식회사 | Prebiotic cosmetic composition having plant fermentation extract |
KR101572580B1 (en) * | 2014-03-27 | 2015-11-27 | 김우연 | Herbal medicine composition having improved adaptability of taking medicine and preparation method thereof |
KR20160126495A (en) * | 2015-04-23 | 2016-11-02 | 나눔허브 주식회사 | Fermented Cynanchum Wilfordii Radix extract, method for preparing the same and use thereof |
-
2016
- 2016-11-16 KR KR1020160152706A patent/KR101883825B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20180055962A (en) | 2018-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101997893B1 (en) | Method of increase the bioactive effectiveness of sprout ginseng | |
KR101464745B1 (en) | Compositions comprising fermentative extract of Orchidaceae for improving functions of skin | |
KR101451981B1 (en) | Compositions comprising fermentative extract of Orchidaceae for improving functions of skin | |
KR101566320B1 (en) | Cosmetic composition comprising an Impatiens balsamina L, Maca, Rosa multiflora Thunberg, Eryobotrya japonica and Pachyrrhizus erosus Complex-fermented extract | |
KR101372789B1 (en) | Composition for Skin External Application Comprising Culture Extract of Rosa Placenta and Functional Food Comprising the Same | |
KR101266180B1 (en) | Vegetable antibacterial composition and cosmetic composition for improving skin using the same | |
KR20200004134A (en) | Composition for improving skin containing grape callus culture media | |
KR102319701B1 (en) | Cosmetic composition comprising mixture of fermented extract of Cirsium japonicum and Moringa oleifera | |
KR101512811B1 (en) | Cosmetic Composition Comprising Reynoutria japonica for. elata Extract for Skin Whitening | |
KR101883825B1 (en) | Manufacturing method of fermented cynanchum wilfordii and fermented cynanchum wilfordii manufactured by same method | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20180138245A (en) | Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same | |
KR101851153B1 (en) | Manufacturing method of fermented rhemannia glutinosa and fermented rhemannia glutinosa manufactured by same method | |
KR102077708B1 (en) | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component | |
KR20220077991A (en) | Composition for anti-inflammation and anti-wrinkle comprising fermentative product of Gryllus bimaculatus extract as effective component | |
KR101797843B1 (en) | A composition having anti-inflammation or anti-bacterial activity comprising Acanthopanax koreanum Nakai stem extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR20150037774A (en) | Preparation of clove having enhanced antioxidative effect | |
KR20190025863A (en) | Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same | |
KR102406982B1 (en) | Composition for improving dermatitis comprising extract of Antennaria dioica having antioxidant activity as effective component | |
KR102644047B1 (en) | A composition for preventing or improving skin wrinkles or skin thermal aging comprising rosa multiflora extracts | |
KR20190087105A (en) | Coating composition for infection control of tattoo area and method of preparing the same | |
KR102541810B1 (en) | Compositions for improving skin comprising angelica and cranberry extracts and uses thereof | |
KR102277824B1 (en) | Method for preparing a natural anti-inflammatory composition comprising sulfate as an active ingredient | |
KR101464406B1 (en) | Composition containing extracts or fractions of tilia taquetii schneid as an active ingredient and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |